- Home
- AGIO vs KLIC Comparison
AGIO vs KLIC Comparison
Compare AGIO & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- KLIC
- Stock Information
- Founded
- AGIO 2007
- KLIC 1951
- Country
- AGIO United States
- KLIC United States
- Employees
- AGIO N/A
- KLIC N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- KLIC Semiconductors
- Sector
- AGIO Health Care
- KLIC Technology
- Exchange
- AGIO Nasdaq
- KLIC Nasdaq
- Market Cap
- AGIO 2.0B
- KLIC 2.4B
- IPO Year
- AGIO 2013
- KLIC N/A
- Fundamental
- Price
- AGIO $35.22
- KLIC $41.69
- Analyst Decision
- AGIO Buy
- KLIC Strong Buy
- Analyst Count
- AGIO 7
- KLIC 5
- Target Price
- AGIO $56.33
- KLIC $52.00
- AVG Volume (30 Days)
- AGIO 621.1K
- KLIC 583.7K
- Earning Date
- AGIO 02-13-2025
- KLIC 02-04-2025
- Dividend Yield
- AGIO N/A
- KLIC 1.90%
- EPS Growth
- AGIO N/A
- KLIC N/A
- EPS
- AGIO 11.64
- KLIC 0.06
- Revenue
- AGIO $36,498,000.00
- KLIC $701,167,000.00
- Revenue This Year
- AGIO $166.22
- KLIC $6.46
- Revenue Next Year
- AGIO $98.36
- KLIC $18.40
- P/E Ratio
- AGIO $3.03
- KLIC $674.75
- Revenue Growth
- AGIO 36.07
- KLIC N/A
- 52 Week Low
- AGIO $27.14
- KLIC $38.20
- 52 Week High
- AGIO $62.58
- KLIC $53.71
- Technical
- Relative Strength Index (RSI)
- AGIO 54.02
- KLIC 39.96
- Support Level
- AGIO $33.25
- KLIC $40.12
- Resistance Level
- AGIO $34.86
- KLIC $44.87
- Average True Range (ATR)
- AGIO 1.33
- KLIC 1.43
- MACD
- AGIO 0.37
- KLIC 0.18
- Stochastic Oscillator
- AGIO 97.99
- KLIC 33.05
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About KLIC Kulicke and Soffa Industries Inc.
Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.